000 | 01784 a2200493 4500 | ||
---|---|---|---|
005 | 20250516131726.0 | ||
264 | 0 | _c20130502 | |
008 | 201305s 0 0 eng d | ||
022 | _a1742-4658 | ||
024 | 7 |
_a10.1111/febs.12130 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNiebler, Stephan | |
245 | 0 | 0 |
_aThe transcription factor activating enhancer-binding protein epsilon (AP-2ε) regulates the core promoter of type II collagen (COL2A1). _h[electronic resource] |
260 |
_bThe FEBS journal _cMar 2013 |
||
300 |
_a1397-408 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aBase Sequence |
650 | 0 | 4 | _aBinding Sites |
650 | 0 | 4 |
_aBone Neoplasms _xmetabolism |
650 | 0 | 4 |
_aCartilage _xmetabolism |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aChondroblastoma _xmetabolism |
650 | 0 | 4 |
_aChondrocytes _xmetabolism |
650 | 0 | 4 | _aChromatin Immunoprecipitation |
650 | 0 | 4 |
_aCollagen Type II _xgenetics |
650 | 0 | 4 |
_aComputational Biology _xmethods |
650 | 0 | 4 | _aConsensus Sequence |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aElectrophoretic Mobility Shift Assay |
650 | 0 | 4 | _aGene Expression Regulation |
650 | 0 | 4 | _aGenes, Reporter |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertrophy _xmetabolism |
650 | 0 | 4 | _aMolecular Sequence Data |
650 | 0 | 4 | _aMutagenesis, Site-Directed |
650 | 0 | 4 | _aNucleotide Motifs |
650 | 0 | 4 | _aPromoter Regions, Genetic |
650 | 0 | 4 |
_aProtein Isoforms _xgenetics |
650 | 0 | 4 |
_aTranscription Factor AP-2 _xgenetics |
650 | 0 | 4 | _aTranscription, Genetic |
700 | 1 | _aBosserhoff, Anja K | |
773 | 0 |
_tThe FEBS journal _gvol. 280 _gno. 6 _gp. 1397-408 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/febs.12130 _zAvailable from publisher's website |
999 |
_c22430708 _d22430708 |